Targeted Oncology

?? We Want to Hear from You! To our community oncology audience: What types of content would be most valuable to you on Targeted Oncology? Whether it’s the latest clinical trial insights, expert interviews, case studies, or practical treatment updates—let us know what you’d find most helpful in your practice. Your feedback helps us deliver content that truly supports your work in oncology! Drop your thoughts in the comments below! ?? #Oncology #TargetedOncology #CommunityOncology #ClinicalInsights

The #FDA granted orphan drug designation to MB-108 for the treatment of patients with malignant glioma. https://lnkd.in/esXb-PcB

Colton Ladbury, MD, discussed new insights from a study and expanded on total marrow irradiation’s potential to transform transplant conditioning. City of Hope https://lnkd.in/ePZaqa6P

A shift in a greater understanding of molecular genetics has led to improved prognostic capabilities in #MDS. https://lnkd.in/eDUKVhFA

Neal Shore, MD, FACS, discussed the background, findings, and implications of a real-world study of enzalutamide and apalutamide in patients with metastatic castration-sensitive prostate cancer. #pcsm #mCSPC https://lnkd.in/eGPAgRk9

In this interview, Domenica Lorusso, MD, PhD, discussed the KEYNOTE-A18 trial, its findings, and implications for oncologists. #gyncsm https://lnkd.in/e8DGXWU4

"The take-home point here is that improvement in progression-free survival does not always mean that a treatment is providing clinical benefit for a patient." - John M. Burke, MD. https://lnkd.in/eAncMYjs

Targeted therapy has transformed cancer treatment, and gene fusions were one of the earliest harbingers of the movement when the FDA approved imatinib. MD Anderson Cancer Center https://ow.ly/4aNc50U2s3h

The #FDA has approved obecabtagene autoleucel as a treatment for adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia. #ALL #leusm https://lnkd.in/ehFgW279

In an interview with Targeted Oncology, Hamlet Gasoyan, MD, discussed the implications of a multiple myeloma study’s findings and their potential impact on clinical practice and patient outcomes. #mmsm | Cleveland Clinic https://lnkd.in/eA84p_Zq